In this article, we detail the experience with immune checkpoint inhibitors in patients with autoimmune disease.
Kathryn E. Beckermann, MD, PhD
Advertisement
Articles by Kathryn E. Beckermann, MD, PhD
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on CancerNetwork
1
Frontline Sunvozertinib Improves PFS vs Chemotherapy in EGFR+ NSCLC
2
The Evolution of Artificial Intelligence in Oncology: Impact on Trials, Workflows, and Outcomes
3
FDA Clears Investigator-Initiated IND for SRN-101 in Recurrent High-Grade Glioma
4
Selinexor Combo Improves Spleen Volume Reduction in Myelofibrosis
5